ubmslateOB-logo-ubm

OB Mobile Logo

Search form

Topics:

Gynecological Oncology

Cervical Cancer: Is a New Detection Method Coming?

A simple blood test using plasma thermogram could serve as an effective new indicator for detecting cervical cancer, including assessment of the cancer’s stage.

Gynecological Oncology

Now that stand-alone HPV tests have been approved, is it worth changing cervical cancer screening recommendations? Juan Felix, MD, weighs in.

The use of intraperitoneal chemotherapy for the treatment of advanced ovarian cancer resulted in a survival benefit over intravenous chemotherapy.

The GnRH agonist goserelin, when given during chemotherapy, may protect against ovarian failure and early menopause in women with breast cancer.

Onset of alopecia within the first 3 cycles of chemotherapy was associated with improved survival in ovarian cancer patients who completed 6 cycles of chemo.

Hormone replacement therapy won't protect postmenopausal women against stroke or heart disease, but don't discount it for symptoms of menopause just yet.

Researchers have discovered that ovarian cancers with ARID1A mutations may be sensitive to treatment with an inhibitor of EZH2 methyltransferase activity.

Clinicians conducting breast examinations who don’t apply enough force during palpation risk missing deeper lesions.

Pages

Subscribe to Gynecological Oncology on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.